DHTs promise faster, more inclusive trials, but they must be implemented correctly. ICON’s latest whitepaper is a must-read for organizations looking to deploy digital measures in their trials. The whitepaper offers step...
- Home
- News & Events
- Events
- Webinars
Webinars
-
Webinars
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Date 16 December 2025 Time 09:30 - 10:30 Location Webinar Timezone EST - America/New York -
Webinars
Riding the data wave: How pharma can navigate disruptions in open claims
Date 8 December 2025 Time 12:00 - 13:00 Location Webinar Timezone EST - America/New York -
Webinars
Becoming a sponsor of choice for high-performing sites
Date 3 December 2025 Time 10:00 - 11:00 Location Webinar Timezone ET - America/New York -
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
Date 18 November 2025 Time 15:00 - 16:00 Location Webinar Timezone CET - Europe/Dublin -
Webinars
Beyond the bench: The advantages of GMP over USP compounding in early phase development
Date 6 November 2025 Time 11:00 - 12:00 Location Webinar Timezone ET - America/New York -
Webinars
Introducing ICON Strategic Solutions FSP Services: How This Model Supports Sponsors in Korea
Date 28 October 2025 Time 14:00 - 15:00 Location Webinar Timezone KST - Asia/Seoul -
Webinars
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
Date 22 October 2025 Time 11:00 - 12:00 Location Webinar Timezone EDT - America/New York -
Webinars
Identifying and mitigating risks in pediatric protocol development: Strategies, tools & access planning
Date 15 October 2025 Time 10:00 - 11:00 Location Webinar Timezone EDT - America/New York -
Webinars
Enhancing clinical trials in obesity by integrating clinical outcome assessment and digital health technologies
Date 7 October 2025 Time 11:00 - 12:00 Location Webinar Timezone ET - America/New York
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.